openPR Logo
Press release

Mexico Biosimilar Market Size, Share & Industry Report | 2033

07-04-2025 07:36 AM CET | Consumer Goods & Retail

Press release from: IMARC GROUP

Mexico Biosimilar Market Size, Share & Industry Report | 2033

Market Overview 2025-2033

The Mexico biosimilar market size reached USD 417.4 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 1,560.8 Million by 2033, exhibiting a growth rate (CAGR) of 14.60% during 2025-2033. The market is growing due to rising chronic disease prevalence, increasing need for affordable biologic therapies, and strengthened regulatory frameworks. Growth is driven by oncology biosimilars, enhanced provider trust, and government cost-control measures, making the industry more accessible, efficient, and competitive.

Key Market Highlights:

✔️ Strong market growth driven by rising healthcare demand and need for cost-effective biologic treatments
✔️ Increasing approvals and availability of biosimilars for oncology, autoimmune, and chronic diseases
✔️ Expanding support from government policies and healthcare providers to enhance biosimilar adoption and accessibility

Request for a sample copy of the report: https://www.imarcgroup.com/mexico-biosimilar-market/requestsample

Mexico Biosimilar Market Trends and Drivers:

The Mexico Biosimilar Market is undergoing notable transformation, driven by regulatory reforms implemented by COFEPRIS (Federal Commission for Protection against Health Risks). In 2023, updated guidelines aligned with EMA and FDA standards introduced a streamlined approval process, cutting biosimilar authorization timelines from 36 to approximately 18 months. As a result, 12 new biosimilar products entered the market in early 2024, with a concentration in oncology and immunology treatments such as trastuzumab, rituximab, adalimumab, and infliximab. Both domestic companies, including Probiomed and Landsteiner, and international firms such as Biocon and Celltrion, are contributing to a broader therapeutic portfolio.

Although biosimilars are typically priced 25-35% lower than reference products, pricing remains a concern. However, the expiration of key patents-for example, those for insulin glargine and etanercept-is expected to increase biosimilar uptake. Challenges persist, particularly regarding pharmacovigilance infrastructure and adverse event traceability. A major growth factor in the Mexico Biosimilar Market Report is demand from the public healthcare sector. Institutions like IMSS and INSABI now include biosimilars in roughly 90% of procurement tenders. As of early 2024, biosimilars accounted for 43% of all biologics dispensed, up from 28% in 2033.

The rise in chronic diseases-such as diabetes, which affects nearly 17% of adults, and approximately 190,000 new cancer diagnoses annually-is driving the need for more affordable treatment options. However, access remains uneven; urban healthcare centers report up to 95% formulary inclusion, while rural areas still face obstacles due to cold-chain logistics. In the private healthcare system, biosimilar penetration remains relatively low at around 22%, though initiatives like step-therapy protocols are gradually improving uptake. The inclusion of biosimilars for rheumatoid arthritis under the expanded Seguro Popular program reflects broader policy support. Nevertheless, high out-of-pocket costs continue to be a barrier for over one-third of households.

Manufacturing capacity is growing, supported by foreign direct investment and national incentives. In 2024, seven contract development and manufacturing organizations (CDMOs) began construction in Guanajuato and Querétaro, aimed at reducing import dependence. This expansion aligns with Mexico's Pharma 4.0 strategy, which includes tax incentives and technology transfer initiatives. Notable developments include a Biocon-Neolpharma joint venture focused on fill-finish operations for monoclonal antibody products. Despite progress, only three domestic companies received WHO prequalification in 2024, underlining challenges in analytical validation and product comparability.

External disruptions, such as API import delays during the 2024 hurricane season, have accelerated nearshoring strategies. Exports to countries like Colombia and Peru now make up 41% of national biosimilar production. However, regulatory differences under the USMCA continue to pose challenges for exports to the U.S. market. The Mexico Biosimilar Market Report highlights consistent market expansion. Valued at over $480 million in early 2024, the market has experienced a CAGR of 14.3% since 2021-far surpassing the broader pharmaceutical sector's average growth of 5.8%.

An aging population, with 14.3% over the age of 60, is contributing to demand across therapeutic areas such as oncology, diabetes, and autoimmune diseases Interchangeability guidelines introduced in 2024, based on ICH Q5E standards, supported wider clinical use of eight monoclonal antibodies, although automatic substitution remains a point of contention among healthcare professionals With the expiration of additional patents, including those for bevacizumab and pegfilgrastim, the market saw an average price drop of 28% in the second half of 2024. Locally produced biosimilars now represent 37% of national sales, up from 19% in 2022.

This growth has been fueled by initiatives like the Strategic Health Industries Fund, which allocated $650 million to boost domestic biomanufacturing. Still, logistics issues-such as the Veracruz port strikes in Q3 2024-exposed supply chain weaknesses, delaying nearly half of biosimilar deliveries during that period. Looking forward, the Mexico Biosimilar Market is projected to represent 58% of the country's biologics market by 2026. Reaching this target will require further investments in rural healthcare distribution, improved reimbursement policies, and enhanced pharmacovigilance systems. With expanding production capabilities, regulatory support, and growing healthcare demand, Mexico is emerging as a leading force in the Latin American biosimilar industry.

Checkout Now: https://www.imarcgroup.com/checkout?id=32102&method=980

Mexico Biosimilar Market Segmentation:

The market report segments the market based on product type, distribution channel, and region:

Study Period:

Base Year: 2024
Historical Year: 2019-2024
Forecast Year: 2025-2033

Breakup by Molecule:

• Infliximab
• Insulin Glargine
• Epoetin Alfa
• Etanercept
• Filgrastim
• Somatropin
• Rituximab
• Follitropin Alfa
• Adalimumab
• Pegfilgrastim
• Trastuzumab
• Bevacizumab
• Others

Breakup by Manufacturing Type:

• In-house Manufacturing
• Contract Manufacturing

Breakup by Indication:

• Auto-Immune Diseases
• Blood Disorder
• Diabetes
• Oncology
• Growth Deficiency
• Female Infertility
• Others

Breakup by Region:

• Northern Mexico
• Central Mexico
• Southern Mexico
• Others

Ask Analyst & Browse full report with TOC & List of Figures: https://www.imarcgroup.com/request?type=report&id=32102&flag=C

Competitive Landscape:

The market research report offers an in-depth analysis of the competitive landscape, covering market structure, key player positioning, top winning strategies, a competitive dashboard, and a company evaluation quadrant. Additionally, detailed profiles of all major companies are included.

About Us:

IMARC Group is a global management consulting firm that helps the world's most ambitious changemakers to create a lasting impact. The company provide a comprehensive suite of market entry and expansion services.

IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.

Contact Us:

IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email: sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
United States: +1-631-791-1145

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Mexico Biosimilar Market Size, Share & Industry Report | 2033 here

News-ID: 4092028 • Views:

More Releases from IMARC GROUP

Event Management Software Market 2025: Size, Trends, Growth Latest Insights and Forecast to 2033
Event Management Software Market 2025: Size, Trends, Growth Latest Insights and …
Event Management Software Market Highlights: • The global event management software market size reached USD 6.63 Billion in 2024. • The market is expected to reach USD 13.4 Billion by 2033, exhibiting a growth rate (CAGR) of 8.1% during 2025-2033. • North America leads the market, accounting for the largest event management software market share due to its advanced corporate sector. • Software accounts for the majority of the market share in the component type segment owing to
Acetonitrile Market Outlook: Trends, Growth Drivers & Key Statistics 2025-2033
Acetonitrile Market Outlook: Trends, Growth Drivers & Key Statistics 2025-2033
Acetonitrile Market Highlights: • The global acetonitrile market size reached USD 392.5 Million in 2024. • The market is expected to reach USD 598.6 Million by 2033, exhibiting a growth rate (CAGR) of 4.5% during 2024-2032. • Asia Pacific leads the market, accounting for the largest acetonitrile market share. • Pharmaceuticals represents the leading end-use segment, owing to its essential role in producing active pharmaceutical ingredients and its widespread use in research activities. • The rising product demand in the
Potassium Chloride Production Cost Analysis 2025: A Detailed Guide from Capital to Commissioning
Potassium Chloride Production Cost Analysis 2025: A Detailed Guide from Capital …
Potassium chloride (KCl) is a white, crystalline inorganic compound commonly used in agriculture as a fertilizer due to its high potassium content, which is essential for plant growth. It also finds applications in the food industry as a salt substitute, in medicine for treating potassium deficiency, and in various industrial processes including metal processing and water treatment. Naturally occurring as the mineral sylvite, potassium chloride is typically extracted through mining
Regenerative Medicine Market Expected to Achieve USD 130.4 Billion Valuation by 2033 with a CAGR of 19.15%
Regenerative Medicine Market Expected to Achieve USD 130.4 Billion Valuation by …
According to the latest report by IMARC Group, titled "Regenerative Medicine Market Report by Type (Stem Cell Therapy, Biomaterial, Tissue Engineering, and Others), Application (Bone Graft Substitutes, Osteoarticular Diseases, Dermatology, Cardiovascular, Central Nervous System, and Others), End User (Hospitals, Specialty Clinics, and Others), and Region 2025-2033", offers a comprehensive analysis of the industry, which comprises insights on the global regenerative medicine market. The report also includes competitor and regional analysis,

All 5 Releases


More Releases for Mexico

Mexico Relocation Guide Helps Thousands Successfully Move to Mexico with Compreh …
Mexico City, Mexico - March 27, 2025 - Since 2019, Mexico Relocation Guide has helped thousands of retirees, digital nomads, and families successfully move to Mexico with its Complete Mexico Relocation Guide-an all-in-one online resource designed to simplify the relocation process. This comprehensive guide provides up-to-date, step-by-step instructions on everything from obtaining residency visas to navigating healthcare, real estate, and taxes, ensuring a seamless transition to life in Mexico. Image: https://www.globalnewslines.com/uploads/2025/03/c0f68758919db47341ba6f02f686214a.jpg A
Mexico Ride Hailing Market 2022 Global Outlook - Uber Mexico, Didi Chuxing, Cabi …
The Mexico Ride Hailing Market report offers an in-depth assessment of market dynamics, the competitive landscape, segments, and regions in order to help readers to become familiar with the Mexico Ride Hailing market. It particularly sheds light on market fluctuations, pricing structure, uncertainties, potential risks, and growth prospects to help players to plan effective strategies for gaining successful in the Mexico Ride Hailing market. Importantly, it allows players to gain
Mexico Rooftop Solar Market Research Report Segmented by Applications, Geography …
Mexico Rooftop Solar Market by Component, Application, Services, and Region- Forecast to 2025 The Global Mexico Rooftop Solar Market Research Report 2021-2025 published by Market Insights Reports is a significant source of keen information for business specialists. It furnishes the Mexico Rooftop Solar business outline with development investigation and historical and futuristic cost analysis, income, demand, and supply information (upcoming identifiers). The research analysts give a detailed depiction of the Mexico
Mexico Rooftop Solar Market Research Report Segmented by Applications, Geography …
Mexico Rooftop Solar Market by Component, Application, Services, and Region- Forecast to 2025 The Global Mexico Rooftop Solar Market Research Report 2021-2025 published by MarketInsightsReports is a significant source of keen information for business specialists. It furnishes the Mexico Rooftop Solar business outline with development investigation and historical and futuristic cost analysis, income, demand, and supply information (upcoming identifiers). The research analysts give a detailed depiction of the Mexico Rooftop Solar
The Mexico Online On-demand Home Services Market , Major Keyplayers - Aliada Inc …
Mexico Online On-demand Home Services Market 2021 Mexico online on-demand home services market offer a range of services within the comfort of home as well as save time and money.  Additionally, these services help in bridging the gap between the real-world services and instant online services with improved efficiency. Recently, the demand for Mexico online on-demand home services marekt has started witnessing huge growth due to convenience and accessibility. The growing
Mexico Agriculture Market, Mexico Agriculture Industry, Mexico Agriculture Grain …
Mexico Agriculture has been crucial sector of the country’s economy traditionally and politically even if it currently accounts for a really little share of Mexico’s GDP. Mexico is one in all the cradles of agriculture with the Mesoamericans emerging domesticated plants like maize, beans, tomatoes, squash, cotton, vanilla, avocados, cacao, number sorts of spices, and more. Domestic turkeys and Muscovy ducks were the solely domesticated fowl within the pre-Hispanic amount and little dogs